Target intelligence / Profile preview

Small nucleolar RNA SNORD79 (SNORD79)

Target
SNORD79
Molecular classification
Non-coding RNA, Small nucleolar RNA (snoRNA), C/D box snoRNA
01

Overview

Small nucleolar RNA SNORD79 (snoRNA U79, Z22) is a non-coding RNA from the C/D box class of snoRNAs involved in the modification of other non-coding RNAs within the nucleolus, particularly by guiding the 2'-O-methylation of specific rRNA residues such as A3809 in 28S rRNA. It is typically found within the intron 7 of the GAS5 gene in humans and also in mice. Like other C/D box snoRNAs, SNORD79 contains conserved sequence motifs (C box and D box) and participates in the formation of small nucleolar ribonucleoprotein complexes, critical for ribosome RNA maturation and function. SNORD79 itself is not a receptor, enzyme, or transporter, and currently has no reported roles as a therapeutic target or clinically relevant biomarker, nor any known drug interactions. Broader research into snoRNAs suggests these molecules collectively may have more expansive roles in gene regulation and disease, particularly cancer, though specific disease roles for SNORD79 have not yet been identified.

Other names
snoRNA U79Z22
02

Mechanism of action

Not applicable, as no drugs are known to act via SNORD79.

03

Biological functions

Guide RNA for site-specific 2'-O-methylation of ribosomal RNA (rRNA), specifically 28S rRNA residue A3809Post-transcriptional modification of small nuclear RNAs (snRNAs)Biogenesis and structural modification of rRNAs and snRNAsRegulation of gene expressionAlternative splicingRNA stability
04

Disease associations

No direct, specific disease association for SNORD79. Some snoRNAs have emerging roles in cancer and other diseases, but associations for SNORD79 specifically are not well characterized.
05

Safety considerations

Not established; as a non-coding RNA involved in housekeeping processes, direct therapeutic targeting would be challenging and could pose technical or specificity issues.
06

Biomarkers

Not established for SNORD79 specifically, although snoRNAs are emerging as biomarkers in oncology.

Beyond the preview

Go deeper on Small nucleolar RNA SNORD79 (SNORD79).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nucleolar RNA SNORD79 (SNORD79).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call